A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 120
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CG
Long Form : central gland
No. Year Title Co-occurring Abbreviation
2019 Automated segmentation of prostate zonal anatomy on T2-weighted (T2W) and apparent diffusion coefficient (ADC) map MR images using U-Nets. ADC, DSC, MR, PZ, T2W, WG
2019 Impact of androgen deprivation therapy on apparent diffusion coefficient and T2w MRI for histogram and texture analysis with respect to focal radiotherapy of prostate cancer. ADT, bpMRI, DWI, EBRT, PCa, PZ, ROC, T2W
2019 Prostate zonal segmentation in 1.5T and 3T T2W MRI using a convolutional neural network. CNN, DSC, MAD, MRI, PCa, PZ
2019 Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated Boost. PZ, ROIs
2019 Tracing of Afferent Connections in the Zebrafish Cerebellum Using Recombinant Rabies Virus. cbln12, CFs, DON, GCs, MON, NLV, PCs, RV
2018 Duplicated Prostate Artery Central Gland Blood Supply: A Retrospective Analysis and Classification System. ---
2018 Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study. BPH, IPSS, LUTS, PAE, QOL
2018 Significant changes of T2 value in the peripheral zone and seminal vesicles after ejaculation. MRI, PZ, SV
2018 Support Vector Machines (SVM) classification of prostate cancer Gleason score in central gland using multiparametric magnetic resonance images: A cross-validated study. AUC, GS, mpMRI, PCa, SVM
10  2017 Prostate Zonal Volumetry as a Predictor of Clinical Outcomes for Prostate Artery Embolization. BPH, IPSS, LUTS, PAE, QOL, WP, ZVi
11  2017 Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging. ADC, Cho, Cit, MRSI, PRESS, PZ, Spm
12  2016 Can prostatic arterial embolisation (PAE) reduce the volume of the peripheral zone? MRI evaluation of zonal anatomy and infarction after PAE. ML, PAE, PZ
13  2016 Characterization of gradient echo signal decays in healthy and cancerous prostate at 3T improves with a Gaussian augmentation of the mono-exponential (GAME) model. GAME, m-E, PZ, ROIs
14  2016 Differential diagnosis of prostate cancer and noncancerous tissue in the peripheral zone and central gland using the quantitative parameters of DCE-MRI: A meta-analysis. CIs, DCE, DCE-MRI, PCa, PZ, SMDs
15  2016 In vivo MRI based prostate cancer localization with random forests and auto-context model. MR, PZ, SBE, TZ
16  2016 Rotating frame relaxation imaging of prostate cancer: Repeatability, cancer detection, and Gleason score prediction. AUC, cw, GS, PCa, PZ, RAFF
17  2015 B-mode and acoustic radiation force impulse (ARFI) imaging of prostate zonal anatomy: comparison with 3T T2-weighted MR imaging. ARFI, mpMRI, PCa, T2WI
18  2015 Comparison of stretched-Exponential and monoexponential model diffusion-Weighted imaging in prostate cancer and normal tissues. ADC, DDC, DWI, PZ
19  2015 Elastic registration of prostate MR images based on estimation of deformation states. DSC, FEM, MAD, MIND, MR, MRI, PZ, TRE, WG
20  2015 MR elastography of prostate cancer: quantitative comparison with histopathology and repeatability of methods. MRE, PZ
21  2015 MRI-based prostate volume-adjusted prostate-specific antigen in the diagnosis of prostate cancer. AUC, HIPAA, MRI, PCa, PSA
22  2015 Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters. LDA, PZ, ROC
23  2015 Prostate cancer identification: quantitative analysis of T2-weighted MR images based on a back propagation artificial neural network model. CAD, MRI, PZ, T2WI
24  2014 A Domain Constrained Deformable (DoCD) Model for Co-registration of Pre- and Post-Radiated Prostate MRI. DoCD, EBRT, PZ
25  2014 Dual optimization based prostate zonal segmentation in 3D MR images. CV, DSC, PZ, T2W, VD, WG
26  2013 Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging. ADC, ADCf, ADCs, AUCs, GH, ROC, SH
27  2013 Prostate 3T-MR spectroscopic imaging without an endorectal surface coil using the MLEV-PRESS sequence. MLEV, MRSI, PRESS, PZ, SD
28  2013 Simultaneous Segmentation of Prostatic Zones Using Active Appearance Models With Multiple Coupled Levelsets. AAM, MLA, PZ
29  2013 Statistical 3D Prostate Imaging Atlas Construction via Anatomically Constrained Registration. AnCoR, DSC, mp, PR, PZ
30  2013 Why prostate tumour delineation based on apparent diffusion coefficient is challenging: an exploration of the tissue microanatomy. ADC, DWI, PZ
31  2012 Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. IPSS, MRI, PSA, PZ, SHIM, WP
32  2012 Apparent diffusion coefficient and sodium concentration measurements in human prostate tissue via hydrogen-1 and sodium-23 magnetic resonance imaging in a clinical setting at 3T. ADC, MR, MRI, PG, TSC
33  2012 Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery. CaP, PZ, QDA, QISes, ROI, RP, T2W
34  2012 Diffusion tensor imaging of normal prostate at 3 T: effect of number of diffusion-encoding directions on quantitation and image quality. ADC, DTI, FA, PZ, SNR
35  2012 Transrectal ultrasound (TRUS) findings of the prostate gland in late onset hypogonadism with testosterone supplementation in correlation with clinical outcome. IPSS, LOH, PSA, PZ, TG, TRUS
36  2011 Discriminating cancer from noncancer tissue in the prostate by 3-dimensional proton magnetic resonance spectroscopic imaging: a prospective multicenter validation study. CC/C, MRSI, PZ
37  2011 Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging for prostate lesions and normal tissue at 3.0-Tesla magnetic resonance imaging. 3.0 T MRI, ADC, CNR, DCE-MRI, DWI, EPI, Gd-DTPA, PZ, ROI, SNR
38  2011 Estrogenic regulation of dopaminergic neurons in the opportunistically breeding zebra finch. DA, TH-ir, VTA
39  2011 Mammal-like organization of the avian midbrain central gray and a reappraisal of the intercollicular nucleus. ICo, PAG
40  2011 MR spectroscopy of the human prostate using surface coil at 3 T: metabolite ratios, age-dependent effects, and diagnostic possibilities. MRSI, PZ, SVS
41  2010 Comparison of peripheral zone and central gland volume in patients undergoing intensity-modulated radiotherapy. ADT, IMRT, MRI, PZ, RT
42  2010 Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. ADC, AUCs, CI, GH, MR, ROC, SH
43  2009 Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue. DCE-MRI, FXL, FXR, PZ
44  2009 Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI. BPH, DCE, PZ, VE
45  2009 Midbrain dopamine neurons reflect affiliation phenotypes in finches and are tightly coupled to courtship. DA, VTA
46  2009 MRI signal intensity based B-spline nonrigid registration for pre- and intraoperative imaging during prostate brachytherapy. DSC, FRE, MI, PZ, TG
47  2008 Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues. ADC, DWI, EPI, PZ
48  2008 Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. ADC, DWI, PZ, TZ
49  2008 Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience. DCE-MRI, MRI, PZ, SNR, TSE
50  2008 Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. ADCs, DW-MRI, PSA, ROIs, T2W
51  2008 Diffusion-weighted MRI in prostate cancer -- comparison between single-shot fast spin echo and echo planar imaging sequences. DW, PCa, PZ
52  2008 Diffusion-weighted single-shot echo planar MR imaging of normal human prostate using different b values. ADC, DWI, PZ, SE-EPI
53  2008 Estrogen is necessary for 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP) infusion to the ventral tegmental area to facilitate social and sexual, but neither exploratory nor affective behavior of ovariectomized rats. SN, VTA
54  2008 Evaluation of the role of magnetization transfer imaging in prostate: a preliminary study. DRE, MTI, MTR, PSA, PZ
55  2008 Infusions of 3alpha,5alpha-THP to the VTA enhance exploratory, anti-anxiety, social, and sexual behavior and increase levels of 3alpha,5alpha-THP in midbrain, hippocampus, diencephalon, and cortex of female rats. DHP, SN, VTA
56  2007 Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut-off value to predict malignancy of the peripheral zone. ADC, DRE, PSA, PZ, ROC, ROIs, TRUS
57  2007 Diffusion tensor magnetic resonance imaging of prostate cancer. ADC, DEC, DTI, FA, FT, MR, MRI, PZ, ROIs
58  2007 Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules. ADCs, DW-MRI, PSA, PZ, ROI
59  2006 Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. PZ, ROIs
60  2004 Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. DCE, MR, MRSI, PZ
61  2004 In vivo diffusion tensor imaging of the human prostate. DTI, DW, FA, PZ, SI
62  2003 Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. AUC, MR, PZ
63  2001 Evaluation of three-dimensional finite element-based deformable registration of pre- and intraoperative prostate imaging. DSC, MR, PZ, TG
64  2000 Combined c-fos and 14C-2-deoxyglucose method to differentiate site-specific excitation from disinhibition: analysis of maternal behavior in the rat. 2-DG, BNST, LHab, MPOA, SEPT, THAL, VTA
65  2000 Neuronal projections to the lateral retrochiasmatic area of sheep with special reference to catecholaminergic afferents: immunohistochemical and retrograde tract-tracing studies. BNST, LS, PBN, SON
66  1999 Midbrain central gray is involved in mediation of cholinergic inputs to the rostral ventrolateral medulla of the rat. PPT, RVLM
67  1998 Metabolic mapping of the brain in pregnant, parturient and lactating rats using fos immunohistochemistry. AHA, AM, Arc, BST, DPB, DR, LC, LH, LS, MaPVN, MiTg, MPA, PaPVN, Pe, PH, PV, SN, Sol, SON, SPF, SuM, VLM, VMH
68  1998 Temporal coincidence between the excitation of ventromedial hypothalamic efferents and the induction of lordosis reflex in ovariectomized estrogen-primed rats. VMN
69  1996 Lesions of the central gray block conditioned fear as measured with the potentiated startle paradigm. ASR
70  1996 Somatostatin in the pontine reticular formation modulates fear potentiation of the acoustic startle response: an anatomical, electrophysiological, and behavioral study. ASP, PnC
71  1994 Lesions of the central gray block the sensitization of the acoustic startle response in rats. ASR, CA, PnC
72  1993 Estrogen-sensitive neurons in the female rat ventral tegmental area: a dual route for the hormone action. POA, VTA
73  1992 Midbrain central gray: influence on medullary sympathoexcitatory neurons and the baroreflex in rats. RVLM
74  1991 Midbrain central grey: regional haemodynamic control and excitatory amino acidergic mechanisms. RVLM
75  1990 Behavioral effects of 5-HT receptor ligands in the aversive brain stimulation, elevated plus-maze and learned helplessness tests. ---
76  1990 Connections between the pontine central gray and the ventromedial hypothalamus are essential for lordosis in female rats. VMH
77  1990 Different mechanisms mediate beta-endorphin- and morphine-induced inhibition of the tail-flick response in rats. ---
78  1990 Effects of midbrain and medullary stimulation on spinomesencephalic tract cells in the cat. NRM, RFs, SMT
79  1990 [Responses of midbrain central gray neurons activated by hypothalamic paraventricular nucleus (PVH) stimulation to somatic afferent input in rats]. ---
80  1988 Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. ACE, BNST, CS, LH
81  1988 Dual progesterone action in diencephalon facilitates the induction of sexual receptivity in estrogen-primed golden hamsters. MPO, VMH
82  1988 Suppression of human growth hormone (GH)-releasing hormone-induced GH secretion in pentobarbital-anesthetized rats after electrical stimulation of the midbrain central gray and several raphe nuclei. GH, Pe
83  1987 Central gray modulation of affective defense is differentially sensitive to naloxone. VM
84  1987 GABA-benzodiazepine modulation of aversion in the medial hypothalamus of the rat. MH
85  1986 Approach and escape responses to mesencephalic central gray stimulation in rats: effects of morphine and naloxone. ---
86  1986 Escape behavior produced by the blockade of glutamic acid decarboxylase (GAD) in mesencephalic central gray or medial hypothalamus. GABA, GAD, MH
87  1986 Modulation of the brain aversive system by GABAergic and serotonergic mechanisms. GABA
88  1986 Modulation of the brain aversive system by GABAergic and serotonergic mechanisms. GABA
89  1986 [Responses of the hypothalamic paraventricular neurons to electrical stimulation of the midbrain central gray (CG) and lemniscus medialis (LM) in the rat]. LM
90  1985 An autoradiographic study of projections ascending from the midbrain central gray, and from the region lateral to it, in the rat. ---
91  1985 Behavioral effects of microinjections of SR 95103, a new GABA-A antagonist, into the medial hypothalamus or the mesencephalic central gray. MH
92  1985 Dose effects of halothane on sensory evoked responses obtained from the cortex, reticular formation and central gray. AAER, AVER, MRF, SCx
93  1985 Effects of hypothalamic lesions on central gray stimulation induced escape behavior and on withdrawal reactions in the rat. MH
94  1985 Prolonged daily inhalation of halothane modifies the dose-response pattern to acute administration of halothane. An electrophysiological study. AAER, PF, SCx, VMH
95  1985 Specificity and neural sites of action of anisomycin in the reduction or facilitation of female sexual behavior in rats. EB, POA, SEPT, VMH
96  1984 Effect of mating on the metabolic activity of the brain and pituitary gland assessed by [14C]2-deoxyglucose in a reflex ovulator, the vole (Microtus agrestis). 2-DG, LH, LQ, RF, rma
97  1984 Electrical activity of the reticular formation during aversive and appetitive conditioning in rats. CS, EP, OC, p-p, RF
98  1984 Flight induced by infusion of bicuculline methiodide into periventricular structures. BM, LH, MH, THIP
99  1984 [Inhibition of mouth-opening reflexes in the cat by stimulation of the central gray and raphe nuclei]. HJR, LJR, RN
100  1983 Diencephalic and mesencephalic efferents of the medial prefrontal cortex in the rat: electrophysiological evidence for the existence of branched axons. MD, SC, SN, VMT